There is particular interest in monoclonal antibody agents to determine whether their immune suppressive effects can reduce the immediate and long-term impact of COVID-19.
Anna Lee Petit, Kaitlin Kennedy, David Ellison, PharmD Candidates 2021 Auburn University Harrison School of Pharmacy
Advertisement
Articles by Anna Lee Petit, Kaitlin Kennedy, David Ellison, PharmD Candidates 2021 Auburn University Harrison School of Pharmacy
Advertisement
Latest Updated Articles
Monoclonal Antibodies Show Promise Treating COVID-19Published: January 13th 2021 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Therapeutic Cancer Vaccines: Are We There Yet?
2
Transforming HER2+ Metastatic Breast Cancer Treatment With Targeted ADC Therapy
3
Emerging Biomarkers Open New Frontiers in Lung Cancer Therapy
4
Subcutaneous Amivantamab Shows Promise in EGFR-Mutated Lung Cancer
5
